Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials

Diabetes - United States
doi 10.2337/db12-0562
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Immunotherapy After Recent-Onset Type 1 Diabetes: Combinatorial Treatment for Achieving Long-Term Remission in Humans?

Review of Diabetic Studies
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Prosecuting Medicare Fraudsters: Lessons Learned From Recent Litigation

Journal of Leadership, Accountability and Ethics
2017English

Heterogeneity in Recent-Onset Type 1 Diabetes - A Clinical Trial Perspective

Diabetes/Metabolism Research and Reviews
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Lessons Drawn From Recent HIV Vaccine Efficacy Trials

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

Recent Advances in Understanding Type 1 Diabetes

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Cardiovascular Outcome Trials of Diabetes Drugs: Lessons Learned

Journal of Clinical Investigation
Medicine
2018English

Lessons Learned From HIV-1 Vaccine Trials: New Priorities and Directions

Nature Immunology
AllergyImmunology
2013English

Recent Advances in Management of Type 1 Diabetes

Australian journal of general practice
Medicine
2019English

The Proteomic Landscape of Patient-Derived CD4+ T Cells in Recent-Onset Type 1 Diabetes

Journal of Proteome Research
BiochemistryChemistry
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy